Send us a Message
Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   
Search RGD Grant Resources Citing RGD About Us Contact Us
Genes Variants Community Projects QTLs Strains Markers Genome Information Ontologies Cell Lines References Download Submit Data
OntoMate (Literature Search) JBrowse (Genome Browser) Synteny Browser (VCMap) Variant Visualizer Multi-Ontology Enrichment (MOET) Gene-Ortholog Location Finder (GOLF) InterViewer (Protein-Protein Interactions) PhenoMiner (Quatitative Phenotypes) Gene Annotator OLGA (Gene List Generator) AllianceMine GViewer (Genome Viewer)
Aging & Age-Related Disease Cancer & Neoplastic Disease Cardiovascular Disease Coronavirus Disease Developmental Disease Diabetes Hematologic Disease Immune & Inflammatory Disease Infectious Disease Liver Disease Neurological Disease Obesity & Metabolic Syndrome Renal Disease Respiratory Disease Sensory Organ Disease
Find Models   new Genetic Models Autism Models Rat PhenoMiner (Quantitative Phenotypes) Chinchilla PhenoMiner Expected Ranges (Quantitative Phenotype) PhenoMiner Term Comparison Hybrid Rat Diversity Panel Phenotypes Phenotypes in Other Animal Models Animal Husbandry Strain Medical Records Phylogenetics Strain Availability Calendar Rats 101 Submissions Photo Archive
Pathways
Rat Community Forum Directory of Rat Laboratories Video Tutorials News RGD Publications RGD Presentations Archive Nomenclature Guidelines Resource Links Laboratory Resources Employment Resources

EXPERIMENTAL CONDITION - ANNOTATIONS

The Clinical Measurement Ontology (CMO), Measurement Methods Ontology (MMO), and Experimental Condition Ontology (XCO) are currently being developed at the Rat Genome Database. For more information about these vocabularies please see Shimoyama et al. Three ontologies to define phenotype measurement data. Front Genet. 2012;3:87. Epub 2012 May 28 or contact us (http://rgd.mcw.edu/contact/index.shtml).
Term:7,12-dimethyltetraphene (DMBA)
go back to main search page
Accession:XCO:0000090 term browser browse the term
Definition:A tetraphene having methyl substituents at the 7- and 12- positions. It is a potent carcinogen and is present in tobacco smoke.
Synonyms:related_synonym: 7,12-DMBA;   7,12-dimethylbenzo[a]anthracene;   9,10-Dimethyl-1,2-benzanthracene;   DMBA
 xref: CHEBI:254496;   MESH:D015127


show annotations for term's descendants           Sort by:
7,12-dimethyltetraphene (DMBA) term browser
Symbol Object Name Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
Q Mamtr1 Mammary tumor resistance QTL 1 IDA RGD PMID:12844486 RGD:631852 NCBI chr 5:12,789,751...113,558,310 JBrowse link
Q Mamtr2 Mammary tumor resistance QTL 2 IDA RGD PMID:14522903 RGD:724790 NCBI chr 2:7,887,772...12,654,247 JBrowse link
Q Mamtr3 Mammary tumor resistance QTL 3 IDA RGD PMID:14522903 RGD:724790 NCBI chr 2:32,373,770...43,665,178 JBrowse link
Q Mamtr4 Mammary tumor resistance QTL 4 IDA RGD PMID:14522903 RGD:724790 NCBI chr 2:16,491,740...61,491,740 JBrowse link
Q Mamtr5 Mammary tumor resistance QTL 5 IDA 65mg/kg body mass RGD PMID:17230524 RGD:1599390 NCBI chr 5:18,873,947...63,873,947 JBrowse link
Q Mamtr6 Mammary tumor resistance QTL 6 IDA 65mg/kg body mass RGD PMID:17230524 RGD:1599390 NCBI chr18:19,278,901...83,218,561 JBrowse link
Q Mamtr7 Mammary tumor resistance QTL 7 IDA 65mg/kg body mass RGD PMID:19052818 RGD:2302423 NCBI chr10:9,658,275...104,670,812 JBrowse link
Q Mamtr8 Mammary tumor resistance QTL 8 IDA 65mg/ml body mass RGD PMID:19052818 RGD:2302423 NCBI chr18:31,359,408...83,218,561 JBrowse link
Q Mcs1 Mammary carcinoma susceptibility QTL 1 IDA RGD PMID:8168109 RGD:61080 NCBI chr 2:7,887,772...23,319,447 JBrowse link
Q Mcs12 Mammary carcinoma susceptibility QTL 12 IDA RGD PMID:16266982 RGD:1559294 NCBI chr 5:58,973,449...60,051,321 JBrowse link
Q Mcs13 Mammary carcinoma susceptibility QTL 13 IDA RGD PMID:16266982 RGD:1559294 NCBI chr 5:63,190,890...69,927,503 JBrowse link
Q Mcs14 Mammary carcinoma susceptibility QTL 14 IDA RGD PMID:16266982 RGD:1559294 NCBI chr 5:76,369,776...80,813,390 JBrowse link
Q Mcs15 Mammary carcinoma susceptibility QTL 15 IDA RGD PMID:16568087 RGD:1581951 NCBI chr10:85,565,469...103,884,409 JBrowse link
Q Mcs16 Mammary carcinoma susceptibility QTL 16 IDA RGD PMID:16596452 RGD:1599317 NCBI chr 1:2,244,390...43,433,040 JBrowse link
Q Mcs17 Mammary carcinoma susceptibility QTL 17 IDA RGD PMID:16596452 RGD:1599317 NCBI chr 1:197,670,404...242,670,404 JBrowse link
Q Mcs18 Mammary carcinoma susceptibility QTL 18 IDA RGD PMID:16596452 RGD:1599317 NCBI chr 2:7,887,772...42,804,738 JBrowse link
Q Mcs19 Mammary carcinoma susceptibility QTL 19 IDA RGD PMID:16596452 RGD:1599317 NCBI chr 5:99,485,997...103,690,167 JBrowse link
Q Mcs2 Mammary carcinoma susceptibility QTL 2 IDA RGD PMID:9584103 RGD:61081 NCBI chr 7:19,032,807...35,526,300 JBrowse link
Q Mcs20 Mammary carcinoma susceptibility QTL 20 IDA RGD PMID:16596452 RGD:1599317 NCBI chr 9:13,533,770...42,791,750 JBrowse link
Q Mcs21 Mammary carcinoma susceptibility QTL 21 IDA RGD PMID:16596452 RGD:1599317 NCBI chr10:28,875,650...52,200,160 JBrowse link
Q Mcs22 Mammary carcinoma susceptibility QTL 22 IDA RGD PMID:16596452 RGD:1599317 NCBI chr18:52,539,763...63,933,058 JBrowse link
Q Mcs23 Mammary carcinoma susceptibility QTL 23 IDA RGD PMID:17404222 RGD:1601189
Q Mcs24 Mammary carcinoma susceptibility QTL 24 IDA RGD PMID:17404222 RGD:1601189 NCBI chr 5:64,719,390...109,719,390 JBrowse link
Q Mcs25 Mammary carcinoma susceptibility QTL 25 IDA 65mg/kg body weight RGD PMID:20737482 RGD:4143380 NCBI chr 6:10,894,415...110,548,006 JBrowse link
Q Mcs26 Mammary carcinoma susceptibility QTL 26 IDA 65mg/kg body weight RGD PMID:20737482 RGD:4143380 NCBI chr 6:106,752,656...132,339,866 JBrowse link
Q Mcs27 Mammary carcinoma susceptibility QTL 27 IDA 65mg/kg body weight RGD PMID:20737482 RGD:4143380 NCBI chr13:43,437,904...47,841,255 JBrowse link
Q Mcs28 Mammary carcinoma susceptibility QTL 28 IDA RGD PMID:21205740 RGD:5684388 NCBI chr 5:77,743,239...78,039,084 JBrowse link
Q Mcs29 Mammary carcinoma susceptibility QTL 29 IDA RGD PMID:21205740 RGD:5684388 NCBI chr 5:77,816,155...77,988,860 JBrowse link
Q Mcs3 Mammary carcinoma susceptibility QTL 3 IDA 65mg/kg body weight RGD PMID:9584103 RGD:61081 NCBI chr 1:102,268,556...147,268,556 JBrowse link
Q Mcs4 Mammary carcinoma susceptibility QTL 4 IDA 65mg/kg body weight RGD PMID:9584103 RGD:61081 NCBI chr 8:16,290,444...61,290,444 JBrowse link
Q Mcs5 Mammary carcinoma susceptibility QTL 5 IDA RGD PMID:11139513 RGD:62417 NCBI chr 5:55,805,606...132,207,589 JBrowse link
Q Mcs6 Mammary carcinoma susceptibility QTL 6 IDA RGD PMID:11139513 RGD:62417 NCBI chr 7:26,737,401...63,902,784 JBrowse link
Q Mcs7 Mammary carcinoma susceptibility QTL 7 IDA RGD PMID:11139513 RGD:62417 NCBI chr10:72,224,939...107,211,142 JBrowse link
Q Mcs8 Mammary carcinoma susceptibility QTL 8 IDA RGD PMID:11139513 RGD:62417 NCBI chr14:3,813,074...24,531,477 JBrowse link
Q Mcsm1 Mammary carcinoma susceptibility modifier QTL 1 IDA RGD PMID:11139513 RGD:62417 NCBI chr 6:58,632,962...103,632,962 JBrowse link

Related Phenotype Data for Term "7,12-dimethyltetraphene (DMBA)" (XCO:0000090)

Rat Strains:
Clinical Measurements:
Experimental Conditions:
Measurement Methods:
Term paths to the root
Path 1
Term Annotations click to browse term
  experimental condition 2376
    disease-inducing agent 223
      disease-inducing chemical 209
        neoplasm-inducing chemical 94
          polycyclic arene 35
            7,12-dimethyltetraphene (DMBA) 35
Path 2
Term Annotations click to browse term
  experimental condition 2376
    chemical 712
      chemical with specified structure 560
        hydrocarbon 39
          cyclic hydrocarbon 35
            polycyclic hydrocarbon 35
              polycyclic arene 35
                7,12-dimethyltetraphene (DMBA) 35
paths to the root